Overall rank by patents
#26,595
of 49,997 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, invox ranks #26,595 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R26595 · Foreign Corporation #26,595 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: eBay Korea Co. Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Easton Diamond Sports · near
37 score
Intelligent Medical… · near
37 score
invoX Pharma · this assignee
37 score
NETZCH-Feinmahltechnik · near
37 score
Think Green · near
37 score
3D Lighting… · lowest
7 score
What this shows invox's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
invoX Pharma Limited is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). By volume, invox sits between e.l.f. Cosmetics, Inc. and pewag austria GmbH.
invoX Pharma Limited shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
e.l.f. Cosmetics, Inc.
10 patents
eBay Korea Co. Ltd.
10 patents
eZono AG
10 patents
iOmniscient Pty Ltd
10 patents
jSonar, Inc.
10 patents
nCino, Inc.
10 patents
ndd Medizintechnik AG
10 patents
pewag austria GmbH
10 patents
invoX Pharma Limited
10 patents
What this shows invoX holds 10 patents at rank #27,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,920 in granted patent volume.
Other assignees with the most granted patents in invoX's primary technology class.
Two PlainPatent-derived peer sets for invoX, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (37 here).
invox's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 1 | 10.0% |
| 2025partial year | 9 | 90.0% |
Top 6 of 6 technology areas
Overall rank by patents
#26,595
of 49,997 tracked assignees
37.2 out of 100
What to do with this data
invoX Pharma Limited's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.